Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-13

FDA Approved: LITHIUM CARBONATE ER — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

The FDA approved a supplemental application for Lithium Carbonate ER from Glenmark Pharmaceuticals, authorizing an extended-release formulation of lithium carbo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lithium carbonate ER (Lithium carbonate)

Snippet

SUPPL AP for LITHIUM CARBONATE ER (LITHIUM CARBONATE)